Table 5.
Prevalence rates of systolic and diastolic blood pressure (BP) and dyslipidemic parameters by baseline variables.a
Variables | Numbers | Metabolic syndrome | Prevalence (%) | Crude relative prevalence (95% CI) |
---|---|---|---|---|
Systolic BP | ||||
<130 | 359 | 87 | 24.2 | 1 |
130–149 | 221 | 153 | 69 | 2.85 (2.06, 3.95)*** |
150–169 | 82 | 58 | 70.7 | 2.91 (1.89, 4.47)*** |
≥170 | 38 | 23 | 60.5 | 2.49 (1.34, 4.54)** |
Diastolic BP | ||||
<80 | 459 | 154 | 34 | 1 |
80–90 | 162 | 104 | 64 | 1.91 (1.38, 2.62)*** |
≥90 | 79 | 63 | 80 | 2.37 (1.59, 3.52)*** |
Triglyceride | ||||
<150 | 473 | 161 | 34 | 1 |
150–299 | 192 | 138 | 72 | 2.10 (1.57, 2.82)*** |
≥300 | 35 | 22 | 63 | 1.84 (0.99, 3.34)* |
HDL-C | ||||
>40 | 254 | 150 | 59 | 1 |
40–49 | 171 | 60 | 35 | 0.59 (0.40, 0.86)** |
≥50 | 275 | 111 | 40.3 | 0.68 (0.501, 0.931)* |
*p < 0.05.
**p < 0.01.
***p < 0.001.
Relative prevalence (with 95% confidence interval). Hypertension: systolic blood pressure ≥130 mmHg or diastolic blood pressure ≥85 mmHg or use of oral antihypertensive medication. Dyslipidemia: triglyceride ≥150 mg/dL or high density lipoprotein-cholesterol (HDL-C)< 0.9 mM in men or < 1.0 mM in women.